» Articles » PMID: 35076339

Protective Effects of and Water Extract Against Memory Deficits Through the Gut-microbiome-brain Axis in an Alzheimer's Disease Model

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2022 Jan 25
PMID 35076339
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Fruits of Vahl (Oleaceae) and seeds of Linne (Caesalpinaceae) have been used to treat inflammation in Asia.

Objective: We examined the alleviation of memory function in Alzheimer's disease (AD) rats fed (FF) and water extracts (CS) and investigated the mechanisms responsible for the effects.

Materials And Methods: Thirty Sprague-Dawley male rats had hippocampal infusions of amyloid-β (AD rats; memory deficit), and ten rats were infused with amyloid-β (non-AD rats; no memory deficit). For eight weeks, all rats freely consumed high-fat diets (43% lard) incorporated with 200 mg/kg body weight assigned aqueous herbal extracts: AD-FF, AD-CS, or without extracts AD-CON (control), non-AD (normal-control).

Results: Memory impairment was prevented in the AD-FF (0.54 ± 0.06-fold) and the AD-CS rats (0.33 ± 0.04-fold) compared to the AD-CON by inhibiting amyloid-β deposition to the levels less than one-fourth of the AD-CON group. The hippocampal pAkt→pGSK-3β→pFOXO1 pathway was attenuated by approximately 3.25-fold in the AD-CON, while AD-FF prevented the attenuation better than AD-CS. The relative intensity of hippocampal tau protein based on β-actin was suppressed with AD-FF (0.68 ± 0.09) and AD-CS (0.96 ± 0.81), compared to AD-CON (1.19 ± 0.13). AD decreased the abundance of by 34.2% and by 23.8% and increased by 181% while the AD-FF, but not the AD-CS, normalised the gut microbiota changes to be similar to the non-AD.

Discussion And Conclusions: FF improved memory deficits better than CS in an AD-induced rat model. The potential neuroprotective benefits of FF against AD may be applicable to human AD therapy with additional clinical research.

Citing Articles

Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine.

Long J, Zhang J, Zeng X, Wang M, Wang N CNS Neurosci Ther. 2024; 30(11):e70101.

PMID: 39508315 PMC: 11541599. DOI: 10.1111/cns.70101.


Recent advancements in the role of phytochemicals and medicinal plants in prophylaxis and management of Alzheimer's disease.

Mishra A, Krishnamurthy S Iran J Basic Med Sci. 2024; 27(11):1357-1369.

PMID: 39386232 PMC: 11459346. DOI: 10.22038/ijbms.2024.77760.16826.


Aberrant bowel movement frequencies coincide with increased microbe-derived blood metabolites associated with reduced organ function.

Johnson-Martinez J, Diener C, Levine A, Wilmanski T, Suskind D, Ralevski A Cell Rep Med. 2024; 5(7):101646.

PMID: 39019013 PMC: 11293344. DOI: 10.1016/j.xcrm.2024.101646.


Acupuncture modulates the gut microbiota in Alzheimer's disease: current evidence, challenges, and future opportunities.

Yan L, Li H, Qian Y, Liu Q, Cong S, Dou B Front Neurosci. 2024; 18:1334735.

PMID: 38495110 PMC: 10940355. DOI: 10.3389/fnins.2024.1334735.


Transcutaneous vagus nerve stimulation: a new strategy for Alzheimer's disease intervention through the brain-gut-microbiota axis?.

Yan L, Li H, Qian Y, Zhang J, Cong S, Zhang X Front Aging Neurosci. 2024; 16:1334887.

PMID: 38476661 PMC: 10927744. DOI: 10.3389/fnagi.2024.1334887.


References
1.
Skovgard K, Agerskov C, Kohlmeier K, Herrik K . The 5-HT receptor antagonist ondansetron potentiates the effects of the acetylcholinesterase inhibitor donepezil on neuronal network oscillations in the rat dorsal hippocampus. Neuropharmacology. 2018; 143:130-142. DOI: 10.1016/j.neuropharm.2018.09.017. View

2.
Zhang Y, Huang N, Yan F, Jin H, Zhou S, Shi J . Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Behav Brain Res. 2017; 339:57-65. DOI: 10.1016/j.bbr.2017.11.015. View

3.
Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D . Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 2004; 5:3. PMC: 373448. DOI: 10.1186/1471-2172-5-3. View

4.
Park S, Yoo K, Hyun J, Kang S . Intermittent fasting reduces body fat but exacerbates hepatic insulin resistance in young rats regardless of high protein and fat diets. J Nutr Biochem. 2016; 40:14-22. DOI: 10.1016/j.jnutbio.2016.10.003. View

5.
Campbell J, Stephenson M, de Courten B, Chapman I, Bellman S, Aromataris E . Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2018; 65(4):1225-1236. PMC: 6218120. DOI: 10.3233/JAD-180263. View